CAR T cells persist for 3 years in young ALL patientsDecember 17, 2015Leukemia, Myelodysplasia, TransplantationALL
Regimen with intensified PEG-ASP feasible in young adults with ALLDecember 16, 2015Leukemia, Myelodysplasia, TransplantationALL
Group recommends adding rituximab to ALL therapyDecember 12, 2015Leukemia, Myelodysplasia, TransplantationALL
CAR exhibits activity in resistant B-cell malignanciesDecember 9, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin Lymphoma
ALL patients over-report their 6MP compliance, researchers sayDecember 8, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
FDA approves generic imatinibDecember 6, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
EC grants conditional approval for blinatumomabNovember 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALL
CHMP recommends pegaspargase for ALLNovember 24, 2015Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Donor CAR T cells treat aggressive ALL in infantNovember 9, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Alternative splicing enables resistance to CTL019October 30, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Germline genetic variation linked to pediatric ALLOctober 29, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Team aims to inhibit Notch safelyOctober 28, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Drug granted breakthrough designation for ALLOctober 20, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALL